Matches in Nanopublications for { ?s ?p "[Primary glioblastomas are characterized by EGFR amplification/overexpression, PTEN mutation, homozygous p16 deletion, and loss of heterozygosity (LOH) on entire chromosome 10, whereas secondary glioblastomas frequently contain p53 mutations and show LOH on chromosome 10q.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP209946.RA4rzpXzGjecaYtCs7qIpKNEDMXlsDUpNENHjwkWuDbpQ130_assertion description "[Primary glioblastomas are characterized by EGFR amplification/overexpression, PTEN mutation, homozygous p16 deletion, and loss of heterozygosity (LOH) on entire chromosome 10, whereas secondary glioblastomas frequently contain p53 mutations and show LOH on chromosome 10q.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209946.RA4rzpXzGjecaYtCs7qIpKNEDMXlsDUpNENHjwkWuDbpQ130_provenance.
- NP286284.RACwqt1e7W0vc2ROCAJSA-qMdXZDUARZ-yUeM8PdSzo-8130_assertion description "[Primary glioblastomas are characterized by EGFR amplification/overexpression, PTEN mutation, homozygous p16 deletion, and loss of heterozygosity (LOH) on entire chromosome 10, whereas secondary glioblastomas frequently contain p53 mutations and show LOH on chromosome 10q.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286284.RACwqt1e7W0vc2ROCAJSA-qMdXZDUARZ-yUeM8PdSzo-8130_provenance.